BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31638179)

  • 41. EphB4 forward-signaling regulates cardiac progenitor development in mouse ES cells.
    Chen K; Bai H; Liu Y; Hoyle DL; Shen WF; Wu LQ; Wang ZZ
    J Cell Biochem; 2015 Mar; 116(3):467-75. PubMed ID: 25359705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Positively charged polymers modulate the fate of human mesenchymal stromal cells via ephrinB2/EphB4 signaling.
    De Luca I; Di Salle A; Alessio N; Margarucci S; Simeone M; Galderisi U; Calarco A; Peluso G
    Stem Cell Res; 2016 Sep; 17(2):248-255. PubMed ID: 27591481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Detecting protein expression of EphrinB2 ligand and its receptor EphB4 in astrocytoma using confocal laser scanning microscopy].
    Xiao HL; Bian XW; Li ZP; Long ZY; Wang D
    Ai Zheng; 2004 Oct; 23(10):1161-5. PubMed ID: 15473927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma.
    Aslam MI; Abraham J; Mansoor A; Druker BJ; Tyner JW; Keller C
    Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6383-8. PubMed ID: 24733895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of EphB4, EphrinB2, and epidermal growth factor receptor in papillary thyroid carcinoma: A pilot study.
    Sharma GK; Dhillon VK; Masood R; Maceri DR
    Head Neck; 2015 Jul; 37(7):964-9. PubMed ID: 24634162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor.
    Noren NK; Yang NY; Silldorff M; Mutyala R; Pasquale EB
    Biochem J; 2009 Aug; 422(3):433-42. PubMed ID: 19552627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
    Noren NK; Foos G; Hauser CA; Pasquale EB
    Nat Cell Biol; 2006 Aug; 8(8):815-25. PubMed ID: 16862147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutations in EPHB4 cause human venous valve aplasia.
    Lyons O; Walker J; Seet C; Ikram M; Kuchta A; Arnold A; Hernández-Vásquez M; Frye M; Vizcay-Barrena G; Fleck RA; Patel AS; Padayachee S; Mortimer P; Jeffery S; Berland S; Mansour S; Ostergaard P; Makinen T; Modarai B; Saha P; Smith A
    JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34403370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bidirectional ephrinB2‑EphB4 signaling regulates the osteogenic differentiation of canine periodontal ligament stem cells.
    Zhu S; Liu Z; Yuan C; Lin Y; Yang Y; Wang H; Zhang C; Wang P; Gu M
    Int J Mol Med; 2020 Mar; 45(3):897-909. PubMed ID: 31985015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers.
    Liersch-Löhn B; Slavova N; Buhr HJ; Bennani-Baiti IM
    Int J Cancer; 2016 Mar; 138(5):1220-31. PubMed ID: 26414866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A synthetic bivalent peptide ligand of EphB4 with potent agonistic activity.
    Fan T; Liang B; Nie L; Wang J; Zhang H; Ciechanover A; Xu Y; An J; Huang Z
    Eur J Med Chem; 2022 Dec; 244():114804. PubMed ID: 36208510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutants.
    Krebs LT; Starling C; Chervonsky AV; Gridley T
    Genesis; 2010 Mar; 48(3):146-50. PubMed ID: 20101599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ligand-dependent EphB4 activation serves as an anchoring signal in glioma cells.
    Kawahara Y; Furuta T; Sabit H; Tamai S; Dong Y; Jiapaer S; Zhang J; Zhang G; Oishi M; Miyashita K; Hayashi Y; Nakada M
    Cancer Lett; 2019 May; 449():56-65. PubMed ID: 30776480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.
    Du E; Li X; He S; Li X; He S
    Mol Biol Rep; 2020 Jun; 47(6):4681-4690. PubMed ID: 32488576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of Ephrin B2 Reverse Signaling Abolishes Multiple Myeloma Pathogenesis.
    Sasine JP; Kozlova NY; Valicente L; Dukov J; Tran DH; Himburg HA; Kumar S; Khorsandi S; Chan A; Grohe S; Li M; Kan J; Sehl ME; Schiller GJ; Reinhardt B; Singh BK; Ho R; Yue P; Pasquale EB; Chute JP
    Cancer Res; 2024 Mar; 84(6):919-934. PubMed ID: 38231476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electric Acupuncture Treatment Promotes Angiogenesis in Rats with Middle Cerebral Artery Occlusion Through EphB4/EphrinB2 Mediated Src/PI3K Signal Pathway.
    Wu Y; Hu R; Zhong X; Zhang A; Pang B; Sun X; Zhu G
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105165. PubMed ID: 33360522
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distribution of EphB4 and EphrinB2 in normal and malignant urogenital tissue.
    Ozgür E; Heidenreich A; Dagtekin O; Engelmann U; Bloch W
    Urol Oncol; 2011; 29(1):78-84. PubMed ID: 19272799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intermittent parathyroid hormone promotes cementogenesis via ephrinB2-EPHB4 forward signaling.
    Li T; Wang H; Lv C; Huang L; Zhang C; Zhou C; Zou S; Duan P
    J Cell Physiol; 2021 Mar; 236(3):2070-2086. PubMed ID: 32740946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attenuation of ephrinB2 reverse signaling decreases vascularized area and preretinal vascular tuft formation in the murine model of oxygen-induced retinopathy.
    Taylor AC; Mendel TA; Mason KE; Degen KE; Yates PA; Peirce SM
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5462-70. PubMed ID: 22789927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation.
    Wang Y; Menendez A; Fong C; ElAlieh HZ; Chang W; Bikle DD
    J Bone Miner Res; 2014 Aug; 29(8):1900-13. PubMed ID: 24677183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.